267 related articles for article (PubMed ID: 25916722)
1. Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.
Li D; Lu CJ; Hao G; Wright H; Woodward L; Liu K; Vergari E; Surdo NC; Herring N; Zaccolo M; Paterson DJ
Hypertension; 2015 Jul; 66(1):190-8. PubMed ID: 25916722
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity.
Liu K; Li D; Hao G; McCaffary D; Neely O; Woodward L; Ioannides D; Lu CJ; Brescia M; Zaccolo M; Tandri H; Ajijola OA; Ardell JL; Shivkumar K; Paterson DJ
JCI Insight; 2018 May; 3(9):. PubMed ID: 29720569
[TBL] [Abstract][Full Text] [Related]
3. Modulation by brain natriuretic peptide of GABA receptors on rat retinal ON-type bipolar cells.
Yu YC; Cao LH; Yang XL
J Neurosci; 2006 Jan; 26(2):696-707. PubMed ID: 16407567
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptide-induced catecholamine release from cardiac sympathetic neurons: inhibition by histamine H3 and H4 receptor activation.
Chan NY; Robador PA; Levi R
J Pharmacol Exp Ther; 2012 Dec; 343(3):568-77. PubMed ID: 22923736
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of Phosphodiesterase 2A in Hypertension.
Seifert R
Hypertension; 2015 Jul; 66(1):13-4. PubMed ID: 25916726
[No Abstract] [Full Text] [Related]
6. C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function.
Buttgereit J; Shanks J; Li D; Hao G; Athwal A; Langenickel TH; Wright H; da Costa Goncalves AC; Monti J; Plehm R; Popova E; Qadri F; Lapidus I; Ryan B; Özcelik C; Paterson DJ; Bader M; Herring N
Cardiovasc Res; 2016 Dec; 112(3):637-644. PubMed ID: 27496871
[TBL] [Abstract][Full Text] [Related]
7. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of natriuretic peptides on vasopressin neurons mediated through cGMP and cGMP-dependent protein kinase in vitro.
Akamatsu N; Inenaga K; Yamashita H
J Neuroendocrinol; 1993 Oct; 5(5):517-22. PubMed ID: 8680419
[TBL] [Abstract][Full Text] [Related]
9. An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition.
Chan NY; Seyedi N; Takano K; Levi R
Circulation; 2012 Jan; 125(2):298-307. PubMed ID: 22158783
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Neuronal Ca2+ Channel Linked to Heightened Sympathetic Phenotype in Prohypertensive States.
Larsen HE; Bardsley EN; Lefkimmiatis K; Paterson DJ
J Neurosci; 2016 Aug; 36(33):8562-73. PubMed ID: 27535905
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Herring N; Zaman JA; Paterson DJ
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
[TBL] [Abstract][Full Text] [Related]
13. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
[TBL] [Abstract][Full Text] [Related]
14. Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons.
Wang L; Henrich M; Buckler KJ; McMenamin M; Mee CJ; Sattelle DB; Paterson DJ
J Mol Cell Cardiol; 2007 Dec; 43(6):717-25. PubMed ID: 17961591
[TBL] [Abstract][Full Text] [Related]
15. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
[TBL] [Abstract][Full Text] [Related]
16. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
17. B-Type Natriuretic Peptide Modulates Pulmonary Vein Arrhythmogenesis: A Novel Potential Contributor to the Genesis of Atrial Tachyarrhythmia in Heart Failure.
Lin YK; Chen YC; Chen YA; Yeh YH; Chen SA; Chen YJ
J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1462-1471. PubMed ID: 27571932
[TBL] [Abstract][Full Text] [Related]
18. PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways.
Vettel C; Lämmle S; Ewens S; Cervirgen C; Emons J; Ongherth A; Dewenter M; Lindner D; Westermann D; Nikolaev VO; Lutz S; Zimmermann WH; El-Armouche A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1246-52. PubMed ID: 24531807
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide enhances the endothelium-independent cAMP and vasorelaxant responses of calcitonin gene-related peptide in rat aorta.
Fiscus RR; Lu L; Tu AW; Hao H; Yang L; Wang X
Neuropeptides; 1998 Dec; 32(6):499-509. PubMed ID: 9920447
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
